P
EXEL icon

&Partners’s Exelixis EXEL Stock Holding History

&Partners’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.95M Buy
35,727
+16,684
+88% +$812K 0.01% 1046
2026
Q1 		$814K Buy
19,043
+4,826
+34% +$207K ﹤0.01% 1418
2025
Q4 		$623K Buy
14,217
+30
+0.2% +$1.24K ﹤0.01% 1495
2025
Q3 		$586K Sell
14,187
-4,260
-23% -$171K ﹤0.01% 1364
2025
Q2 		$812K Sell
18,447
-3,791
-17% -$152K 0.01% 1089
2025
Q1 		$822K Buy
22,238
+15,432
+227% +$550K 0.01% 902
2024
Q4 		$236K Buy
+6,806
New +$221K ﹤0.01% 1462

Other funds holding EXEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

&Partners's EXEL Position: Q2 2026 in Review

&Partners increased its Exelixis (EXEL) stake by 88% in Q2 2026, buying an estimated $812K and bringing the position to 35,727 shares worth $1.95M. The position accounts for 0.01% of the portfolio, ranked #1046.

&Partners first reported a position in EXEL in Q4 2024 and has held it in 7 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • &Partners held 35,727 shares of Exelixis worth $1.95M as of Q2 2026.
  • &Partners bought 16,684 Exelixis shares in Q2 2026, an estimated $812K.
  • Exelixis made up 0.01% of &Partners's portfolio in Q2 2026, its #1046 holding.
  • &Partners first reported a position in Exelixis in Q4 2024 and has held it in 7 quarters since.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.